Author

C. Dincer

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioengineering· 1 Cancer Biology· 1 Cell Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:CRISPR screen· 2 Approach:experimental assay· 2 Organism:human· 2 Approach:deep learning· 1 Research Focus:drug response / drug discovery· 1 Research Focus:gene regulatory network inference· 1 Approach:genetic perturbation / CRISPR· 1 Research Focus:variant effect prediction· 1

Frequent Co-Authors

A. R. Bassett· 1 shared B. Newman· 1 shared C. Hardy· 1 shared C. M. Cattaneo· 1 shared E. Goncalves· 1 shared E. Karakoc· 1 shared E. Voest· 1 shared F. Gibson· 1 shared

Activity by Year

2021-2022 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. R. Bassett

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Optimised whole-genome CRISPR interference screens identify ARID1A-dependent growth regulators in human induced pluripotent stem cells

S. Usluer, P. Hallast, L. Crepaldi, Y. Zhou, K. Urgo, C. Dincer, J. Su, G. Noell, K. Alasoo, O. El Garwany, S. Gerety, B. Newman, O. M. Dovey, L. Parts

The paper optimizes CRISPR interference screens in human iPSCs using dCas9-KRAB-MeCP2, identifies ARID1A-dependent growth regulators, and finds proteasome-related genes as synthetic lethal targets.

bioRxiv · Oct 3, 2022 · PreprintCell Biology

Base editing screens map mutations affecting IFNγ signalling in cancer

M. A. Coelho, E. Karakoc, S. G. Bhosle, E. Goncalves, T. Burgold, S. Cooper, C. M. Cattaneo, V. Veninga, S. Consonni, C. Dincer, S. F. Vieira, F. Gibson, S. Barthorpe, C. Hardy, J. Rein, , M. J. Garnett

This study uses base editing to identify mutations affecting IFNγ signalling in cancer, revealing loss- and gain-of-function variants with clinical relevance.

bioRxiv · Mar 29, 2022 · PreprintCancer Biology

OptoAssay - Light-controlled Dynamic Bioassay Using Optogenetic Switches

N. Urban, M. Hoerner, W. Weber, C. Dincer

The paper introduces OptoAssay, a light-controlled bioassay that enables bidirectional movement of components using optogenetic switches, eliminating the need for pumps, valves, and external readout devices.

bioRxiv · Nov 6, 2021Bioengineering